Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study

Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study

Sandro Loche,1 Shankar Kanumakala,2 Philippe Backeljauw,3 Karl Otfried Schwab,4 Alfonso M Lechuga-Sancho,5– 7 Altaher Esmael,8 Dragan Urosevic,9 Anca Boldea,8 Markus Zabransky8 1Endocrinologia Pediatra e Centro, Screening Neonatale, Ospedale Pediatrico Microcitemico “A. Cao”, Cagliari, Italy; 2Unive...

Full description

Bibliographic Details
Main Authors: Loche S, Kanumakala S, Backeljauw P, Schwab KO, Lechuga-Sancho AM, Esmael A, Urosevic D, Boldea A, Zabransky M
Format: Article
Language:English
Published: Dove Medical Press 2024-03-01
Series:Drug Design, Development and Therapy
Subjects:
omnitrope
patro children
growth hormone
pediatrics
growth hormone deficiency
small for gestational age
Online Access:https://www.dovepress.com/safety-and-effectiveness-of-a-biosimilar-recombinant-human-growth-horm-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/safety-and-effectiveness-of-a-biosimilar-recombinant-human-growth-horm-peer-reviewed-fulltext-article-DDDT

Similar Items